INTRODUCTION
============

Worldwide, breast cancer is the most common type of cancer in women and the second leading cause of cancer death among women. In 2015, about 246,000 cases of breast cancer were diagnosed in the United States of America \[[@b1-jlm-07-055]\]. In Korea, approximately 141,300 women were diagnosed with invasive or non-invasive breast cancer in 2013. However, due to the improvement and development of new treatments and drugs, 90% of cancer patients now survive at least five years after diagnosis \[[@b2-jlm-07-055]\]. Breast cancer treatments include chemotherapy, surgery, radiation therapy, hormone therapy, and anticancer drugs \[[@b3-jlm-07-055]\]. It is highly probable that various therapies have positively influenced breast cancer patients and survivors. However, the most remarkable aspect is that the rates of breast cancer incidence and mortality have decreased. For this reason, the physical fitness of breast cancer survivors is an important concern \[[@b4-jlm-07-055]\].

Exercise and physical activity are vital to reduce risk factors and improve physical fitness, psychological controls, and quality of life in breast cancer survivors \[[@b5-jlm-07-055],[@b6-jlm-07-055]\]. Several studies have reported the benefits of exercise for breast cancer survivors. Also, exercise promotes social interaction during and after treatment and can significantly enhance the ability of cancer patients and survivors to cope with fatigue, lymphedema, and bone metastasis \[[@b7-jlm-07-055]\]. However, the most important point is that, after diagnosis, most breast cancer patients and survivors reduce their rate of participation in physical activity by 11% \[[@b8-jlm-07-055]\].

Many studies have described the effects of exercise training on the levels of biomarkers, including various adipokines. Some studies have suggested that tai chi exercise induces changes in inflammatory cytokine levels \[[@b9-jlm-07-055]\]. However, there have been controversial results regarding the effects of exercise on leptin and adiponectin levels. Some studies have demonstrated that serum and plasma leptin levels decreased while adiponectin levels increased after weight loss accompanied by exercise. On the other hand, other studies have indicated that plasma adiponectin level did not change in a 6-month combined exercise intervention program \[[@b10-jlm-07-055],[@b11-jlm-07-055]\]. However, research on the effects of different types of exercise on physical fitness and various biomarkers in breast cancer is still in an early stage.

The purpose of the present review was to outline current research trends on the benefits of combined exercise (CE), aerobic exercise (AE), and resistance exercise (RE) on physical fitness and biomarker levels in breast cancer survivors. In this review, we focused on the demonstrated health benefits of physical fitness and various biomarkers and the informed benefits of risk management for breast cancer survivors according to the type of exercise.

MATERIALS AND METHODS
=====================

We searched the electronic databases of PubMed and PubMed Central from 2012 to July 2016. Our search was limited to human studies in the English language. We only retained experimental research studies in which participants had been diagnosed with stage I--IIIc breast cancer and were free of metastatic disease and other cancers after surgery and anticancer treatments. We reviewed 118 papers, of which 114 were considered potentially relevant. Ultimately, we found 24 research papers that met our inclusion criteria.

RESULTS
=======

In total, we evaluated 24 studies involving 1,351 subjects and divided them according to their focus on aerobic, resistance, or combined exercise. In the case of aerobic exercise, the intensity ranged from 50% to 85% maximal heart rate and from 2 to 3 days per week. Resistance exercise included body-weight and Thera-Band resistance and ranged from 1 to 3 sets of 8 to 20 reps. Combined exercise included both resistance and aerobic exercise.

1. Aerobic exercise and improved physical fitness
-------------------------------------------------

Four trials examined the effects of aerobic exercise on physical fitness in breast cancer survivors. The trials ranged from 6 to 24 weeks in duration, and the number of subjects in the trials ranged from 33 to 69. Adherence to the interventions ranged from 50% to 80% maximum intensity. The percentage of body fat, maximal oxygen consumption (VO~2max~), hand grip strength and 6-min walking test performance were determined in four studies, and 1-mile running test performance was determined in four studies. In the four studies for aerobic exercise reported that significant physical fitness outcomes in breast cancer survivors. Aerobic exercise improved the percentage of body fat, VO~2max~, hand grip strength, 6-min walking test performance and 1-mile running test performance.

2. Resistance exercise and improved physical fitness
----------------------------------------------------

Four trials examined the effects of resistance exercise on physical fitness in breast cancer survivors. The trials ranged from 8 weeks to 12 months in duration, and the number of subjects in the trials ranged from 20 to 249. The chest, hip, arm, and leg strengths were determined in four studies. In the four studies for resistance exercise reported that significant physical fitness outcomes in breast cancer survivors. Resistance exercise improved chest, hip, arm, and leg strength.

3. Combined exercise and improved physical fitness
--------------------------------------------------

Four trials examined the effects of combined exercise on physical fitness in breast cancer survivors. The trials ranged from 12 weeks to 3 months in duration, and the number of subjects in the trials ranged from 28 to 58. Adherence to the interventions ranged from 60% to 85% maximal heart rate and from 8 to 15 reps using body-weight, Thera-Band and machine resistance. The chest, hip, arm, and leg strength; functional walking performance; and predicted VO~2max~ were determined. In the four studies for combined exercise that significant physical fitness outcomes in breast cancer survivors. Combined exercise improved the chest, hip, arm, and leg strength; functional walking performance; and predicted VO~2max~ ([Table 1](#t1-jlm-07-055){ref-type="table"}).

4. Aerobic exercise and improved biomarkers
-------------------------------------------

Four trials examined the effects of aerobic exercise on biomarker levels in breast cancer survivors. The trials ranged from 6 to 15 weeks in duration, and the number of subjects in the trials ranged from 23 to 94. Adherence to the interventions ranged from 55% to 80% maximal heart rate. The levels of inflammatory cytokines, metabolic biomarkers, and cancer biomarkers were determined in four studies. Only one study reported that aerobic exercise improved the levels of cancer markers. Giallauria and colleagues conducted a randomized controlled trial involving a supervised aerobic exercise intervention among 94 breast cancer survivors. The serum level of High-mobility group box 1 (HMGB-1) was obtained at baseline and at the 12-week follow-up. The authors reported that aerobic exercise reduced the serum level of HMGB-1, which consequently enhanced the health status of cancer patients.

5. Resistance exercise and improved biomarkers
----------------------------------------------

Four trials examined the effects of resistance exercise on biomarker levels in breast cancer survivors. The trials ranged from 24 hours to 3 months in duration, and the number of subjects in the trials ranged from 12 to 103. The levels of inflammatory cytokines, metabolic biomarkers, and cancer biomarkers were determined in four studies. Two trials reported that resistance exercise improved serum interleukin-6 (IL-6) and tumor necrosis factor-*α* (TNF-*α*) levels.

6. Combined exercise and improved biomarkers
--------------------------------------------

Four trials examined the effects of combined exercise on biomarker levels in breast cancer survivors. The trials ranged from 8 weeks to 6 months in duration, and the number of subjects in the trials ranged from 16 to 79. The levels of inflammatory cytokines, metabolic biomarkers, and cancer biomarkers were determined in four studies. Two trials reported that combined exercises improved leptin, total cholesterol, and cutaneous T-cell-attracting chemokine (CTACK) levels ([Table 2](#t2-jlm-07-055){ref-type="table"}).

DISCUSSION
==========

In recent years, it has been suggested that it is necessary to continue to study the guidelines for exercise prescriptions for breast cancer survivors, especially the types, localization, and side effects associated with exercise \[[@b42-jlm-07-055]\]. Generally, the available exercise guidelines for breast cancer survivors emphasize the importance of participating in moderate aerobic exercise, recommend with flexibility, and intermittent or minimally mention of resistance exercise \[[@b43-jlm-07-055],[@b44-jlm-07-055]\]. Despite the importance of exercise, up to date, there has been minimal research regarding the effects of different types of exercise on physical fitness and biomarker levels in breast cancer survivors. Therefore, the purpose of this review is to propose the most effective type of exercise by reviewing the effects of each type of exercise on breast cancer survivors.

Some previous studies have suggested that the importance of resistance exercise for breast cancer survivors \[[@b45-jlm-07-055],[@b46-jlm-07-055]\]. Although resistance exercise enhances musculoskeletal strength and bone mineral density, but has smaller effects on body composition and lipid profiles \[[@b17-jlm-07-055],[@b25-jlm-07-055]\]. And also, single-type aerobic exercise interventions improve body composition and some adipokine levels, but do not affect musculoskeletal strength or the levels of biomarkers associated with bone mineral density \[[@b16-jlm-07-055],[@b39-jlm-07-055]\]. In general, we found that combined exercise improves not only body composition and adipokine levels, but also musculoskeletal strength and the levels of biomarkers associated with bone mineral density \[[@b14-jlm-07-055],[@b19-jlm-07-055],[@b21-jlm-07-055],[@b23-jlm-07-055]\]. Therefore, in view of this evidence, we suggest that the type of combined exercise is more effective for breast cancer survivors than single aerobic exercise or resistance exercise.

In conclusion, our review suggests that combined exercise could be considered a beneficial and effective exercise type for breast cancer survivors. Future trials with strict randomized controlled methodology are needed to verify the effects of different types of exercise on physical fitness and the levels of various biomarkers in breast cancer survivors.

###### 

Effects of exercise on physical fitness

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                                            Cancer stage                                          Participants              Mode   Intervention                                        Outcome
  ---------------------------------------------------- ----------------------------------------------------- ------------------------- ------ --------------------------------------------------- -----------------------
  Pinto et al. \[[@b12-jlm-07-055]\] (2005)            Stage I--II                                           3 yrs after treatment.    AE     2 × / wk for 12 wks at 55--65% maximum intensity.   ↑Δ1-mile walking test

  12 control                                           ↓Δ%body fat                                                                                                                                

  12 exercise                                                                                                                                                                                     

  Ohira et al. \[[@b13-jlm-07-055]\] (2006)            Stage I--III                                          Completing treatment.     RE     2 × / wk for 24 wks.                                ↑ΔBench press

  43 control                                                                                                                                                                                      

  43 exercise                                                                                                                                                                                     

  Helen et al. \[[@b14-jlm-07-055]\] (2008)            Stage I--IIIa                                         58 mo. after treatment.   Comb   3 × / wk for 12 wks.                                ↑ΔLeg press\
                                                                                                                                                                                                  ↑ΔChest extension

  Pre-- and post-intervention                          AE: 20 min, cycling and rowing.                                                                                                            

  RE: Whole-body progressive, 10--15 reps, two sets.                                                                                                                                              

  Irwin et al. \[[@b15-jlm-07-055]\] (2009)            Stage I--IIIa                                         6 mo. after treatment.    AE     3 × / wk for 24 wks at 50--80% maximum intensity.   ↓Δ%body fat

  33 control                                                                                                                                                                                      

  36 exercise                                                                                                                                                                                     

  Antonia et al. \[[@b16-jlm-07-055]\] (2010)          N/A                                                   2 yrs after treatment.    AE     Dance exercise.                                     ↓ΔHand grip strength\
                                                                                                                                                                                                  ↓Δ6-min walk

  13 control                                           3 × / wk for 24 wks at 65--80% maximum intensity.                                                                                          

  14 exercise                                                                                                                                                                                     

  Waltman et al. \[[@b17-jlm-07-055]\] (2010)          Stage I--V                                            6 mo. after treatment.    RE     2 × / wk for 24 mo.                                 ↑ΔHip extension

  125 control                                          8--12 reps, two sets.                                 ↑ΔHip flexion                                                                        

  123 exercise                                         ↑ΔKnee extension                                                                                                                           

  ↑ΔKnee flexion                                                                                                                                                                                  

  Winters et al. \[[@b18-jlm-07-055]\] (2011)          Stage I--IIIa                                         1 yr after treatment.     RE     1 × / wk for 12 mo. 8--12 reps, three sets.         ↑ΔBench press

  54 control                                           ↑ΔLeg press                                                                                                                                

  52 exercise                                                                                                                                                                                     

  Laura et al. \[[@b19-jlm-07-055]\] (2012)            Stage I--IIIa                                         2 mo. after treatment.    Comb   2 × / wk for 3 mo.                                  ↑ΔPredicted VO~2max~

  13 control                                           AE: Moderate, 150 min/week.                           ↑ΔBack / leg strength                                                                

  15 exercise                                          RE: Whole-body band exercise, 20 reps.                                                                                                     

  Benton et al. \[[@b20-jlm-07-055]\] (2014)           Stage I--III                                          Completing treatment.     RE     2 × / wk for 8 wks.                                 ↑ΔChest press

  20 pre-- and post-intervention                       10--12 reps, three sets.                                                                                                                   

  Hannah et al. \[[@b21-jlm-07-055]\] (2015)           Stage I--III                                          6 mo. after treatment.    Comb   2 × / wk for 12 mo.                                 ↑ΔVO~2max~

  38 control                                           AE: 60--80% maximum intensity.                                                                                                             

  45 exercise                                          RE: Whole-body progressive, 9--12 reps, three sets.                                                                                        

  Lianne et al. \[[@b22-jlm-07-055]\] (2015)           Stage I--IIIa                                         Completing treatment.     AE     6 wks at 55--80% maximum intensity.                 ↑ΔVO~2max~

  10 control                                                                                                                                                                                      

  23 exercise                                                                                                                                                                                     

  Michael et al. \[[@b23-jlm-07-055]\] (2016)          N/A                                                   17 mo. after treatment.   Comb   3 × / wk for 12 wks.                                ↑ΔTimed up and go

  52 pre-- and post-intervention                       AE: 70--85% maximum intensity.                        ↑ΔLeg press                                                                          

  RE: Whole-body progressive, 8--12 reps, two sets.    ↑ΔChest press                                                                                                                              

  ↑ΔBack scratch                                                                                                                                                                                  

  ↑ΔSingle-leg stand                                                                                                                                                                              
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Notes:↑Increase,↓Decrease.

AE: aerobic exercise, Comb: combined exercise, RE: resistance exercise, reps: repetitions, VO~2max~: maximal oxygen consumption.

###### 

Effects of exercise on mediators of inflammation

  Reference                                           Cancer stage                                           Participants              Mode   Intervention                                        Outcome
  --------------------------------------------------- ------------------------------------------------------ ------------------------- ------ --------------------------------------------------- ---------------
  Martina et al. \[[@b24-jlm-07-055]\] (2016)         Stage I--IIIa                                          Completing treatment.     RE     2 × / wk for 12 wks.                                ↓ΔIL-6
  49 control                                          8--12 reps, three sets.                                                                                                                     
  54 exercise                                                                                                                                                                                     
  Amanda et al. \[[@b25-jlm-07-055]\] (2016)          Stage I--IIIa                                          17 wks after treatment.   RE     3 × / wk for 16 wks.                                ≒ΔTNF-α
  19 control                                          8--10 reps, three sets.                                ≒ΔIL-6                                                                               
  20 exercise                                         ≒ΔIL-10                                                                                                                                     
  ≒Δhs-CRP                                                                                                                                                                                        
  ↓ΔTNF-α                                                                                                                                                                                         
  Nigel et al. \[[@b26-jlm-07-055]\] (2015)           Stage I--IIIc                                          12 mo. after treatment.   RE     15--20 reps, three sets.                            ≒ΔIL-6
  22 control                                          24 hours.                                              ≒ΔTNF-α                                                                              
  20 exercise                                         ≒Δhs-CRP                                                                                                                                    
  Swisher et al. \[[@b27-jlm-07-055]\] (2015)         Stage I--III                                           3 mo. after treatment.    AE     2 × / wk for 12 wks at 60--75% maximum intensity.   ≒Δhs-CRP
  10 control                                          ≒ΔIL-6                                                                                                                                      
  13 exercise                                         ≒ΔTNF-α                                                                                                                                     
  ≒ΔAdiponectin                                                                                                                                                                                   
  ≒ΔInsulin                                                                                                                                                                                       
  ≒ΔLeptin                                                                                                                                                                                        
  Lianne et al. \[[@b22-jlm-07-055]\] (2015)          Stage I--IIIa                                          Completing treatment.     AE     6 wks at 55--80% maximum intensity.                 ≒ΔInsulin
  10 control                                          ≒ΔGlucose                                                                                                                                   
  23 exercise                                         ≒ΔHOMA-IR                                                                                                                                   
  ≒Δhs-CRP                                                                                                                                                                                        
  Giallauria et al. \[[@b28-jlm-07-055]\] (2014)      Stage I                                                N/A                       AE     3 × / wk for 12 wks at 70% maximum intensity.       ↓ΔHMGB-1
  33 control                                                                                                                                                                                      
  62 exercise                                                                                                                                                                                     
  Laura et al. \[[@b19-jlm-07-055]\] (2014)           Stage I--II                                            4 wks after treatment.    Comb   2 × / wk for 3 mo.                                  ≒ΔIL-6
  22 control                                          AE: 48--52 heart reserve.                              ≒ΔIL-8                                                                               
  20 exercise                                         RE: Whole-body band exercise, 15 reps, two sets.       ↓ΔIL-10                                                                              
  ≒ΔTNF-α                                                                                                                                                                                         
  Scott et al. \[[@b29-jlm-07-055]\] (2013)           Stage I--III                                           18 mo. after treatment.   Comb   3 × / wk for 3 mo.                                  ↓ΔLeptin
  38 control                                          AE: 65--85% maximum intensity.                         ↓ΔTotal cholesterol                                                                  
  42 exercise                                         RE: Whole-body band exercise 10--15 min.                                                                                                    
  Tish et al. \[[@b30-jlm-07-055]\] (2016)            N/A                                                    3 yrs after treatment.    Comb   3 × / wk for 12 mo.                                 ≒ΔOsteocalcin
  78 control                                          AE: 65--70% maximal heart rate.                        ≒ΔVitamin D                                                                          
  76 exercise                                         RE: Whole-body progressive, 8 reps, one set.                                                                                                
  Gomez et al. \[[@b31-jlm-07-055]\] (2011)           Stage I--II                                            18 mo. after treatment.   Comb   3 × / wk for 8 wks                                  ↓ΔCTACK
  8 control                                           AE: 70--80% maximal heart rate.                                                                                                             
  8 exercise                                          RE: Whole-body progressive, 12--15 reps, three sets.                                                                                        
  Adrian et al. \[[@b32-jlm-07-055]\] (2005)          Stage I--IIIb                                          Completing treatment.     AE     2 × / wk for 15 wks at 70--75% maximum intensity.   ≒ΔIL-1
  28 control                                          ≒ΔIL-4                                                                                                                                      
  25 exercise                                         ≒ΔIL-6                                                                                                                                      
  ≒ΔIL-10                                                                                                                                                                                         
  ≒ΔTNF-α                                                                                                                                                                                         
  Sara et al. \[[@b33-jlm-07-055]\] (2012)            Stage I--IIIa                                          12 mo. after treatment.   Comb   3 × wk for 6 mo.                                    ≒ΔIL-6
  37 intervention                                     AE: 60--80% maximum intensity.                         ≒Δhs-CRP                                                                             
  38 control                                          RE: Whole-body yoga exercise, 30 min.                  ≒ΔTNF-α                                                                              
  Nora et al. \[[@b35-jlm-07-055]\] (2013)            Stage I--III                                           12 mo. after treatment.   Comb   2 × / wk                                            ↓ΔC-peptide
  19 pre-- and post-intervention                      AE: walking 3--3.5 mph 30 min.                                                                                                              
  RE: Whole-body progressive, 8--12 reps, two sets.                                                                                                                                               
  Guinan et al. \[[@b36-jlm-07-055]\] (2013)          Stage I--III                                           2 mo. after treatment.    AE     2 × / wk for 8 wks at 45--65% maximum intensity.    ≒ΔInsulin
  10 control                                          ≒ΔHbA1c                                                                                                                                     
  16 exercise                                                                                                                                                                                     
  Campbell et al. \[[@b37-jlm-07-055]\] (2012)        Stage I--IIIa                                          3 mo. after treatment.    AE     2 × / wk for 24 wks at 60% maximum intensity.       ↓ΔHDL-c
  14 pre-- and post-intervention                                                                                                                                                                  
  Emily et al. \[[@b38-jlm-07-055]\] (2014)           Stage I--III                                           5 yrs after treatment.    RE     2 × / wk for 6 mo.                                  ≒Δhs-CRP
  12 pre-- and post-intervention                      8--12 reps, two sets.                                                                                                                       
  Befort et al. \[[@b39-jlm-07-055]\] (2012)          Stage I--IIIc                                          3 mo. after treatment.    AE     225 min / wk for 12 wks.                            ↓ΔInsulin
  36 pre-- and post-intervention                      Moderate walking, 225 min per week.                    ↓ΔLeptin                                                                             
  Kerri et al. \[[@b18-jlm-07-055]\] (2011)           Stage I--IIIa                                          1 yr after treatment.     RE     12 mo.                                              ↑ΔOsteocalcin
  54 control                                          8--12 reps, three sets.                                                                                                                     
  52 exercise                                                                                                                                                                                     
  Waltman et al. \[[@b17-jlm-07-055]\] (2010)         Stage I--II                                            6 mo. after treatment.    RE     2 × / wk for 24 mo.                                 ↓ΔAlkphase B
  113 control                                         8--12 reps, two sets.                                  ↓ΔNTx                                                                                
  110 exercise                                                                                                                                                                                    
  Irwin et al. \[[@b15-jlm-07-055]\] (2009)           Stage I--IIIa                                          6 mo. after treatment.    AE     3 × / wk for 24 wks at 50--80% maximum intensity.   ↓ΔInsulin
  33 control                                          ↓ΔIGF-1                                                                                                                                     
  36 exercise                                         ↓ΔIGFBP-3                                                                                                                                   
  Ligibel et al. \[[@b40-jlm-07-055]\] (2007)         Stage I--III                                           After 3 mo. treatment.    Comb   16 wks.                                             ↓ΔInsulin
  42 intervention                                     RE: whole-body exercise, 50 min per week.                                                                                                   
  40 control                                          AE: 90 min per week.                                                                                                                        

Notes:↑Increase,↓Decrease, ≒ No change.

AE: aerobic exercise, Comb: combined exercise, RE: resistance exercise, reps: repetitions, VO~2max~: maximal oxygen consumption. IL-1: interleukin-1, IL-4: interleukin 4, IL-6: interleukin-6, IL-8: interleukin-8, IL-10: interleukin-10, TNF-α: tumor necrosis factor-α, CTACK: cutaneous T-cell-attracting chemokine, hs-CRP: high sensitivity C-reactive protein, HbA1c: hemoglobin A1c, HDL-c: high-density lipoprotein cholesterol, HOMA-IR: homeostatic model assessment of *β*-cell function and insulin resistance, HMGB-1: high-mobility group box-1, Alkphase-B: bone-specific alkaline phosphatase, NTx: N-telopeptides of type 1 collagen, IGF-1: insulin-like growth factor gene-1, IGFBP-3: insulin-like growth factor-binding protein-3.
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